Articles related to ‘Hematology, cancer chemotherapy and related’
-
Animation on the mechanism of action of GnRH agonists and antagonists in the treatment of prostate cancer
-
P-glycoprotein: animation showing its role in chemotherapy resistance
-
Anticoagulants MCQs for test review
-
FDA recommendations on clopidogrel (Plavix) because of decreased response and PPI interactions
-
EMEA recommends new contraindications for toremifene (Fareston): long QT interval and related heart diseases
-
Protein bound paclitaxel (Abraxane) mechanism of action. 3D video animations
-
Thrombin inhibition: video animation explaining bivalirudin (Angiomax, Angiox) mechanism of action
-
Rivaroxaban (Xarelto) for the prevention of venous thromboembolism (VTE): SMC review
-
Bivalirudin (Angiox) for acute coronary syndromes: SMC review
-
Nilotinib (Tasigna) for chonic myeloid leukemia: Health Canada evaluation
-
Methylnaltrexone (Relistor) for opioid induced constipation: SMC review
-
Recomendations for the use of erlotinib (Tarceva) in patients with liver disease
-
Off-label intravitreal use of bevacizumab (Avastin): reports of ocular side effects
-
Dabigatran (Pradaxa, Pradax) for the prevention of VTE. Mechanism of action, indications, contraindications, pharmacodynamics and pharmacokinetics.
